NO129095B - - Google Patents
Download PDFInfo
- Publication number
- NO129095B NO129095B NO00919/69A NO91969A NO129095B NO 129095 B NO129095 B NO 129095B NO 00919/69 A NO00919/69 A NO 00919/69A NO 91969 A NO91969 A NO 91969A NO 129095 B NO129095 B NO 129095B
- Authority
- NO
- Norway
- Prior art keywords
- virus
- culture
- rhinopneumonitis
- passages
- sheep
- Prior art date
Links
- 241000700605 Viruses Species 0.000 claims description 51
- 210000004027 cell Anatomy 0.000 claims description 15
- 238000004113 cell culture Methods 0.000 claims description 15
- 206010000210 abortion Diseases 0.000 claims description 12
- 231100000176 abortion Toxicity 0.000 claims description 12
- 229960005486 vaccine Drugs 0.000 claims description 12
- 241001494479 Pecora Species 0.000 claims description 10
- 241000283086 Equidae Species 0.000 claims description 9
- 241000283073 Equus caballus Species 0.000 claims description 8
- 210000000056 organ Anatomy 0.000 claims description 6
- 241000282887 Suidae Species 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 4
- 230000009385 viral infection Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 210000003292 kidney cell Anatomy 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 description 13
- 241000699673 Mesocricetus auratus Species 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000002238 attenuated effect Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102000004407 Lactalbumin Human genes 0.000 description 4
- 108090000942 Lactalbumin Proteins 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 4
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 239000012981 Hank's balanced salt solution Substances 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 210000004381 amniotic fluid Anatomy 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ASXBYYWOLISCLQ-UHFFFAOYSA-N Dihydrostreptomycin Natural products O1C(CO)C(O)C(O)C(NC)C1OC1C(CO)(O)C(C)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O ASXBYYWOLISCLQ-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- ASXBYYWOLISCLQ-HZYVHMACSA-N dihydrostreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O ASXBYYWOLISCLQ-HZYVHMACSA-N 0.000 description 2
- 229960002222 dihydrostreptomycin Drugs 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000230501 Equine herpesvirus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- IBUIVNCCBFLEJL-UHFFFAOYSA-M sodium;phosphoric acid;chloride Chemical compound [Na+].[Cl-].OP(O)(O)=O IBUIVNCCBFLEJL-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/27—Equine rhinopneumonitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/82—Viral vaccine for equine species, e.g. horses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1692043A DE1692043C3 (de) | 1968-03-06 | 1968-03-06 | Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO129095B true NO129095B (xx) | 1974-02-25 |
Family
ID=6989015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00919/69A NO129095B (xx) | 1968-03-06 | 1969-03-05 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3725542A (xx) |
| AT (1) | AT286497B (xx) |
| BE (1) | BE729460A (xx) |
| CA (1) | CA942190A (xx) |
| DE (1) | DE1692043C3 (xx) |
| DK (1) | DK122823B (xx) |
| FI (1) | FI45766C (xx) |
| FR (1) | FR2003343A1 (xx) |
| GB (1) | GB1263181A (xx) |
| IE (1) | IE32655B1 (xx) |
| NL (1) | NL149378B (xx) |
| NO (1) | NO129095B (xx) |
| SE (1) | SE348495B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110433A (en) * | 1976-04-23 | 1978-08-29 | Philips Roxane, Inc. | Equine rhinopneumonitis virus |
| US4083958A (en) * | 1976-09-13 | 1978-04-11 | The University Of Kentucky Research Foundation | Inactivated equine rhinopneumonitis virus vaccine and use thereof |
| US4225582A (en) * | 1979-03-08 | 1980-09-30 | The University Of Illinois Foundation | Vaccine for equine rhinopneumonitis |
-
1968
- 1968-03-06 DE DE1692043A patent/DE1692043C3/de not_active Expired
-
1969
- 1969-02-20 FI FI690547A patent/FI45766C/fi active
- 1969-02-27 NL NL696903064A patent/NL149378B/xx not_active IP Right Cessation
- 1969-02-28 IE IE268/69A patent/IE32655B1/xx unknown
- 1969-03-04 SE SE02943/69A patent/SE348495B/xx unknown
- 1969-03-05 NO NO00919/69A patent/NO129095B/no unknown
- 1969-03-05 CA CA044,687A patent/CA942190A/en not_active Expired
- 1969-03-05 DK DK121969AA patent/DK122823B/da not_active IP Right Cessation
- 1969-03-06 AT AT222369A patent/AT286497B/de not_active IP Right Cessation
- 1969-03-06 GB GB02004/69A patent/GB1263181A/en not_active Expired
- 1969-03-06 BE BE729460D patent/BE729460A/xx not_active IP Right Cessation
- 1969-03-06 FR FR6906217A patent/FR2003343A1/fr active Pending
-
1972
- 1972-01-24 US US00220456A patent/US3725542A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3725542A (en) | 1973-04-03 |
| FR2003343A1 (xx) | 1969-11-07 |
| FI45766C (fi) | 1972-09-11 |
| IE32655L (en) | 1969-09-06 |
| DE1692043A1 (de) | 1971-07-29 |
| DK122823B (da) | 1972-04-17 |
| DE1692043B2 (de) | 1978-08-10 |
| SE348495B (xx) | 1972-09-04 |
| FI45766B (xx) | 1972-05-31 |
| NL149378B (nl) | 1976-05-17 |
| NL6903064A (xx) | 1969-09-09 |
| IE32655B1 (en) | 1973-10-17 |
| CA942190A (en) | 1974-02-19 |
| GB1263181A (en) | 1972-02-09 |
| DE1692043C3 (de) | 1979-04-12 |
| AT286497B (de) | 1970-12-10 |
| BE729460A (xx) | 1969-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Botros et al. | Adverse response of non‐indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine | |
| US6001370A (en) | Attenuated strain of the virus causing the porcine reproductive respiratory syndrome (PRRS), and vaccines | |
| US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| US3520972A (en) | Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains | |
| Paton et al. | Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes | |
| Brock et al. | Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine | |
| US3080291A (en) | Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom | |
| US4571386A (en) | Feline infectious peritonitis vaccine | |
| NO129095B (xx) | ||
| JP2002247979A (ja) | マレック病ワクチンおよびその製造方法 | |
| US4083958A (en) | Inactivated equine rhinopneumonitis virus vaccine and use thereof | |
| US4291019A (en) | Vaccine for infectious bovine rhinotracheitis | |
| Inaba et al. | Propagation in laboratory animals and cell cultures of a virus from cattle with bovine epizootic fever | |
| US3331736A (en) | Modified laryngotracheitis vaccine | |
| Zimmerman et al. | Vaccination with a multivalent modified-live virus vaccine administered one year prior to challenge with bovine viral diarrhea virus type 1b and 2a in pregnant heifers | |
| US4312947A (en) | Process for the preparation of a vaccine against panleucopenia of the cat | |
| JP3043353B2 (ja) | ワクチン | |
| US3096247A (en) | Infectious rhinotracheitis virus attenuated in lamb cell tissue cultures | |
| US3432391A (en) | Attenuated infectious canine hepatitis live virus vaccine and method of producing same | |
| RU2236253C2 (ru) | Вакцина эмульсионная инактивированная против репродуктивно-респираторного синдрома свиней | |
| FUKUNAGA | quine Viral Arteritis: Diagnostic and Control Measures | |
| CA1216234A (en) | Preparation of modified strains of bovine diarrhoea virus and vaccines containing them | |
| CA1289881C (en) | Vaccine against herpes simplex | |
| Messner et al. | Bovine adenoviruses—IV. Two mixed antigens for routine serodiagnosis by complement fixation reaction | |
| US7803527B2 (en) | Inactivated bovine herpes virus-1 and methods |